Scrip: industry news and insights
ASCO Data Show A Battle Ahead For Roche And Genmab’s Lymphoma Bispecifics
27 May 2022
Roche looks set to gain first and second place in the race to bring CD3Xcd20s to market – but Genmab...
weekly audio catch-up on global biopharma developments
Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip's global team, in this podcast version of Five Must-Know Things.
This episode covers insights for the business week ended 7 January 2022, including: new mRNA deal for Pfizer Inc. and BioNTech SE; court ruling helps Novartis AG’s Gilenya; first cut-price generic Paxlovid launched; breaking down BridgeBio Pharma, Inc.’s Phase III failure; and a look at gene editing companies to watch at JP Morgan.
This and all our other podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.
Stories mentioned in this episode:
(Beximco Delivers First Cut-Price Generic Paxlovid)
(Stock Watch Bridgebios Endpoint A Bridge Too Far)
(GeneEditing Companies To Watch At JP Morgan)
Scrip: industry news and insights
27 May 2022
Roche looks set to gain first and second place in the race to bring CD3Xcd20s to market – but Genmab...
Scrip: industry news and insights
27 May 2022
Recent executive changes in the industry include C-suite changes at Radius Health and Sorrento Therapeutics. Meanwhile, new directors were appointed...
Scrip: industry news and insights
27 May 2022
Torrent is recalibrating strategy with the addition of chronic therapies from Dr. Reddy’s while it folds up an unsustainable liquids...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: